Prot #BLU-285-1406: Observational Study Evaluating the Long-Term Safety and Efficacy of Avapritinib in the First-Line Treatment of Patients with Platelet-Derived Growth Factor Receptor Alpha (PDGFRA) D842V-Mutated Gastrointestinal Stromal Tumour (GIST)

Project: Research project

Project Details

StatusActive
Effective start/end date7/17/247/17/27

Funding

  • INC Research, LLC (Prot #BLU-285-1406 // Prot #BLU-285-1406)
  • Blueprint Medicines Corporation (Prot #BLU-285-1406 // Prot #BLU-285-1406)